A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) | MicrobiomeTrials
A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2025-01-27Est. Completion: 2027-07
Enrollment target: 4 participants
Locations
City of Hope /ID# 253904, Duarte, California, United States
City of Hope - Orange County Lennar Foundation Cancer Center /ID# 267158, Irvine, California, United States
Intermountain Health St Vincent Regional Hospital - Cancer Centers of Montana /ID# 264622, Billings, Montana, United States
Atrium Health Levine Cancer Institute /ID# 265136, Charlotte, North Carolina, United States
Duplicate_Duke Cancer Center /ID# 258707, Durham, North Carolina, United States
MD Anderson Cancer Center /ID# 253713, Houston, Texas, United States
Royal Prince Alfred Hospital /ID# 263129, Sydney, New South Wales, Australia
Gold coast University Hospital /ID# 255785, Southport, Queensland, Australia
Austin Health /ID# 256776, Heidelberg, Victoria, Australia
Royal Perth Hospital /ID# 256464, Perth, Western Australia, Australia